The gene Enhancer of split [E(spl)] of Drosophila is part of a gene complex [E(SPL)-C, the function of which is required for control of the binary decision between neural and epidermal cell fates in uncommitted cells of the neurogenic ectoderm (1) . Results of genetic and cell transplantation experiments suggest that E(SPL)-C is a key element in establishment of epidermal commitment of neuroectodermal cells (2, 3) . Seven members of this complex, including the E(spl) gene, encode proteins characterized by basic and helix-loop-helix domains (the bHLH motif) (ref. 4 ; E.K., H. Schrons, F. Grawe, and J. A. Campos-Ortega, unpublished data), suggesting a function in DNA binding and transcriptional regulation. bHLH proteins have been found in many organisms, ranging from yeast (5, 6) and plants (7) to animals, and some of them are of crucial importance for control of developmental pathways, such as myogenesis or neurogenesis (see refs. 1, 8, and 9 for reviews). The common characteristic of these proteins is their suggested DNA-binding capacity, mediated by the bHLH domains (10) , and in several cases bHLH proteins have been shown to act as transcriptional activators (e.g., see refs. [11] [12] [13] . The HLH domain is required for dimerization, which is a prerequisite for DNA binding, whereas target specificity is mediated by the basic domain, which lies adjacent to the HLH motif (14, 15) . Unlike most other bHLH proteins, the E(SPL) protein and the other six bHLH proteins of the E(SPL)-C complex each contains aproline residue in its basic domain (ref. 4 ; E.K., H. Schrons, F. Grawe, and J. A. Campos-Ortega, unpublished data), which, in the case of MyoD (15) , has been reported to be incompatible with DNA binding. Thus, the DNA-binding capabilities of the E(SPL)-C products are open to question.
In many instances, conclusions drawn from in vitro DNAbinding assays suffer from the drawback that no in vivo test is available to prove the relevance of the observed effects for the organism or the cell itself. In the case of the E(spl)D mutation, a dominant mutation of the gene E(spl), we have an ideal tool in hand with which to study both in vivo and in vitro the effects of modifications of the gene. This mutation renders expression of the otherwise recessive phenotype of split (sp), an allelomorph of the neurogenic gene Notch (N), dominant (16) (17) (18) (19) Fig. 1 ) into the Bluescript vector (Stratagene) and cloned as Pst I/Kpn I fragments (using the restriction sites of the polylinker) into the transformation vector pW8 (26) . To produce the recombinant inserts m8+/D and m8D/+, we used the Xho I site at nucleotide 3523 (4) . For the m9,mJOD construct, phage clones were isolated from a genomic library made from E(spl)D DNA in the EMBL-4 phage vector (27) . Two fragments from two different phages, a Bgi II (map unit 13.1)/BamHI (site within the inserted DNA) fragment and a BamHI/Sal I (map unit 21.9) fragment (map units according to ref. 21) were fused to build a complete m9,mJOD fragment (Fig. 1A) .
In Vitro Mutagenesis. In vitro mutagenesis essentially followed the method described in ref. 28 , with modifications as described by the supplier of the system (Amersham). Primers used are summarized below, numbering (in parentheses) is according to ref. 4 , << indicates primers in antisense orientation. Nucleotide sequences that do not correspond to wild type are underlined, nucleotides in boldface represent introduced Kpn I restriction sites used for cloning or introduced stop codons. In vitro mutagenesis was confirmed by sequencing, using the chain-termination method (29) , or by testing for the newly introduced restriction site, followed by sequencing. For construction of m8+ del, two Kpn I sites were introduced into the m8+ construct at the borders of the desired deletion by in vitro mutagenesis, using the primers CTACAAGAACTTGGTACCATTCCACGAAGC (nucleotides 3717-3746) and GGAAATCTATTTTGGTACCGAC-CGAGTTG (nucleotides 4200-4228). After removing the fragment between the two Kpn I sites, the remaining Kpn I site was eliminated by further in vitro mutagenesis, using Germ-Line Transformation. Germ-line transformation experiments were carried out essentially as described (30) , using the transformation vector pW8 (26) . Transposase was supplied either by coinjection of the A2-3 helper plasmid (31) or by using wiw; A2-3/A2-3 embryos as hosts (32 
RESULTS
We have previously shown that the ability to enhance the spi lects on the phenotype is associated with the mutant E(spl)D gene: trans- As the m8D fragment used earlier carries several lesions (Fig. 1) , we have used different hybrid constructs and mutations for germ-line transformation to localize the region responsible for the enhancement of spi to the distal part of the mutant E(spl) gene (Fig. 3 a-d) . This region carries a deletion of 483 base pairs, which removes 3' noncoding DNA as well as a sequence encoding the last 56 amino acids of the wild-type product, which are replaced by a sequence of 9 amino acids (4) (Fig. 1B) . Hence, the mutant phenotype may be due to (i) truncation of the protein per se, (ii) the additional amino acid sequence, (iii) deletion of the 3' region of the transcription unit, (iv) other changes not associated with the deletion, or (v) any combination of these effects. To exclude the possibility that other minor sequence differences detected in the m8D construct (4) might be responsible for this effect, we reconstructed the same deletion in an m8+ fragment (m8+.del), which produced the same protein as m8D, and we obtained the same result as with m8D (Fig. 3e) . To distinguish between the other possibilities, we carried out a set of manipulations on the m8+ and the m8D constructs and analyzed their effects on the spi phenotype in transgenic females (Fig. 3 e-g ). Strikingly, although the introduction of a termination codon at the corresponding position in the wild-type and mutant genes (m8+ stop and m8DMstoP; Fig. 3 f and g) should result in production of the same truncated protein, these two constructs differ significantly in the degree to which they enhance spi. Whereas one copy of the m8DstoP construct is sufficient to render spl dominant and thus behaves like the m8D construct (data not shown), the m8+,stoP construct gives rise to dominant expression of spI only when present in two copies (Fig. 2 D and E) . Thus the truncation of the E(SPL) protein is not sufficient to provoke the same strong enhancement as observed with m8D. As the only difference between the m8+ ,StOp and m8DstoP constructs resides at the nucleic acid level (see Fig. 3fand g) , we conclude that the DNA, which is deleted in the mutant, carries the responsible element and we assume that the strong dominant enhancement of spi is caused by the loss of a regulatory sequence in the mutant DNA in combination with a truncation of the protein. This regulatory element could act on either the transcriptional or the posttranscriptional levele.g., by changing the stability of the RNA-but its precise definition as well as analysis of the molecular basis of its function await further experiments.
The high degree of amino acid sequence similarity between the E(SPL) protein and other members of the bHLH class, which bind via the basic domain to DNA and can activate transcription (14) , led us to assume that the wild-type and mutant versions of this protein are also involved in DNA binding. However, the E(SPL) protein as well as all other members of the E(SPL)-C complex contain a proline residue in the basic domain (4) at a position where most other bHLH proteins, except the Drosophila protein hairy (H) (43), contain either a threonine or an asparagine residue. Replacement of an alanine adjacent to this threonine in the MyoD protein by a proline has been shown to abolish DNA binding to its target sequence (15) . To address the question of the role of the basic domain of the E(SPL)D protein, we introduced various amino acid exchanges (see Material and Methods; Fig. 3 h-j) and tested their effects on the spi phenotype after germ-line transformation. In addition, we directly assayed bacterially expressed wild-type and E(SPL)D protein and some modified versions of the wild-type protein for their ability to bind specifically to DNA in vitro. By band-shift assays, we could demonstrate that both the wild-type and the E(SPL)D proteins specifically bind to a sequence in the E(spl) promoter in vitro. Furthermore, DNA binding is totally abolished after neutralization ofpart of the basic domain (Fig.  4) . In vivo, neutralization of part of the basic domain of the E(SPL)D protein (m8D bd-; Fig. 3h ) leads to complete loss of spl-enhancing capacity, suggesting loss of an essential function of the protein. Replacement of the proline by a threonine (m8DP-T; Fig. 3i) or asparagine residue (m8DP-N; Fig. 3j ), the two residues that are found at the equivalent position in the basic domains of most of the other bHLH proteins, results in only minor modification of the strong spi enhancement: transgenic flies carrying the m8DP-N construct exhibit a slightly stronger enhancement, judged by more severe irregularities of the ommatidia, those with the m8DP-T construct have a slightly reduced enhancement compared to those with the m8D construct itself (for assessment of the spi phenotype; see legend to Fig. 3 ). Proteins carrying these exchanges [E(SPL)+ P-N and E(SPL)+ ,P-T] are still able to bind to the specific target sequence in vitro (Fig. 4) . These results clearly demonstrate that the basic domains of the E(SPL)+ and E(SPL)D proteins are functionally important and bind to DNA, despite the presence of a proline residue, and that neutralization of part of this domain not only abolishes DNA binding in vitro but also leads to loss of in vivo function of the E(SPL)D protein, as shown by its inability to enhance the spi phenotype.
DISCUSSION
The bHLH proteins of the E(SPL)-C differ from most of the other members of this family by the presence of a proline residue in the basic domain. This has led to speculation as to whether this domain can function in DNA binding at all, since a proline residue can confer a kink in a-helical structures (44 
